On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from Kenneth Steiner, on the adoption of a Board policy that the Chairperson of the Board be an independent director was not approved.